Analysis of the Prognostic Factors of Extensive Disease Small-Cell Lung Cancer Patients in Tokushima University Hospital-Reference-Cited by-同舟云学术

Analysis of the Prognostic Factors of Extensive Disease Small-Cell Lung Cancer Patients in Tokushima University Hospital

Published:2016 Issue:3.4 Volume:63 Page:286-293
ISSN:1343-1420
Container-title:The Journal of Medical Investigation
language:en
Short-container-title:J. Med. Invest.

Author:

Ogino Hirokazu¹,Hanibuchi Masaki¹,Kakiuchi Soji¹²,Saijo Atsuro¹,Tezuka Toshifumi¹,Toyoda Yuko¹,Tobiume Makoto¹,Otsuka Kenji¹,Sakaguchi Satoshi¹³,Goto Hisatsugu¹,Arisawa Kokichi⁴,Nishioka Yasuhiko¹

Affiliation:

1. Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University

2. Department of Oncology, Tokushima Municipal Hospital

3. Department of Respiratory Medicine, Tokushima Prefectural Central Hospital

4. Department of Preventive Medicine, Graduate School of Biomedical Sciences, Tokushima University

Publisher

University of Tokushima Faculty of Medicine

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.jstage.jst.go.jp/article/jmi/63/3.4/63_286/_pdf

Reference31 articles.

1. 1. Govindan R, Page N, Morgensztern D, Read W, Tierney R, Vlahiotis A, Spitznagel EL, Piccirillo J: Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 24: 4539-44, 2006

2. 2. Minna JD, Kurie JM, Jacks T: A big step in the study of small cell lung cancer. Cancer Cell 4: 163-6, 2003

3. 3. Turrisi AT 3rd, Kim K, Blum R, Sause WT, Livingston RB, Komaki R, Wagner H, Aisner S, Johnson DH: Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 340: 265-71, 1999

4. 4. Noda K, Nishiwaki Y, Kawahara M, Negoro S, Sugiura T, Yokoyama A, Fukuoka M, Mori K, Watanabe K, Tamura T, Yamamoto S, Saijo N; Japan Clinical Oncology Group: Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med 346: 85-91, 2002

5. 5. Hanna N, Bunn PA Jr, Langer C, Einhorn L, Guthrie T Jr, Beck T, Ansari R, Ellis P, Byrne M, Morrison M, Hariharan S, Wang B, Sandler A: Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer. J Clin Oncol 24: 2038-43, 2006

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Holistic immunomodulation for small cell lung cancer;Seminars in Cancer Biology;2023-01

2. Prediction of Efficacy of Immunotherapy for Extensive Stage Small Cell Lung Cancer;Advances in Clinical Medicine;2023

3. CAMSAP1 Mutation Correlates With Improved Prognosis in Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy;Frontiers in Cell and Developmental Biology;2022-01-11

4. High mutations in fatty acid metabolism contribute to a better prognosis of small‐cell lung cancer patients treated with chemotherapy;Cancer Medicine;2021-09-26

5. Chinese Medicine Treatment Prolonged Survival in Small Cell Lung Cancer Patients: A Clinical Observation;Chinese Journal of Integrative Medicine;2020-06-04